122 related articles for article (PubMed ID: 19008704)
21. PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAalpha1) prevents the passage of tissue-type plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity.
Roussel BD; Hommet Y; Macrez R; Schulz T; Petersen KU; Berezowski V; Cecchelli R; Ali C; Vivien D
Thromb Haemost; 2009 Sep; 102(3):606-8. PubMed ID: 19718485
[No Abstract] [Full Text] [Related]
22. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Morris DC
N Engl J Med; 2008 Dec; 359(26):2841; author reply 2841. PubMed ID: 19115492
[No Abstract] [Full Text] [Related]
23. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Schwamm LH; Fonarow GC
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115490
[No Abstract] [Full Text] [Related]
24. Statins and stroke.
Rodríguez-Yáñez M; Agulla J; Rodríguez-González R; Sobrino T; Castillo J
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):157-66. PubMed ID: 19124419
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator, but not systemic antibiotic therapy, prevents abscess formation in an experimental model of secondary peritonitis.
Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T
Br J Surg; 2008 Oct; 95(10):1287-93. PubMed ID: 18720460
[TBL] [Abstract][Full Text] [Related]
26. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?
Talelli P; Greenwood RJ
Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436
[TBL] [Abstract][Full Text] [Related]
27. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Fitzpatrick AE; Noone I; O'Shea DD
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
[No Abstract] [Full Text] [Related]
28. [Current status and future of recombinant tissue plasminogen activator for acute ischemic stroke].
Sakaida H; Taki W
No Shinkei Geka; 2009 Nov; 37(11):1067-83. PubMed ID: 19938663
[No Abstract] [Full Text] [Related]
29. [Guidelines for the general management of patients with acute ischemic stroke].
Chang YJ; Ryu SJ; Chen JR; Hu HH; Yip PK; Chiu TF;
Acta Neurol Taiwan; 2008 Dec; 17(4):275-94. PubMed ID: 19280874
[TBL] [Abstract][Full Text] [Related]
30. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival.
Milionis HJ; Giannopoulos S; Kosmidou M; Panoulas V; Manios E; Kyritsis AP; Elisaf MS; Vemmos K
Neurology; 2009 May; 72(21):1816-22. PubMed ID: 19470963
[TBL] [Abstract][Full Text] [Related]
31. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
[TBL] [Abstract][Full Text] [Related]
32. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
[TBL] [Abstract][Full Text] [Related]
33. Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study.
Jovanović DR; Beslać-Bumbasirević Lj; Budimkić M; Pekmezović T; Zivković M; Kostić VS;
Clin Neurol Neurosurg; 2009 Nov; 111(9):729-32. PubMed ID: 19647928
[TBL] [Abstract][Full Text] [Related]
34. Acute ischemic stroke: Not a moment to lose.
Miller J; Mink J
Nursing; 2009 May; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
[TBL] [Abstract][Full Text] [Related]
35. Thrombolysis for stroke in Poland: first 2 years of experience.
Czlonkowska A; Kobayashi A; Skowronska M; Niewada M; Sarzynska-Dlugosz I
Int J Stroke; 2006 May; 1(2):111-2. PubMed ID: 18706057
[No Abstract] [Full Text] [Related]
36. Dedicated stroke units and outcome.
Bornstein NM
Isr Med Assoc J; 2005 Nov; 7(11):739. PubMed ID: 16309000
[No Abstract] [Full Text] [Related]
37. Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial.
Amlie-Lefond C; Chan AK; Kirton A; deVeber G; Hovinga CA; Ichord R; Stephens D; Zaidat OO;
Neuroepidemiology; 2009; 32(4):279-86. PubMed ID: 19223687
[TBL] [Abstract][Full Text] [Related]
38. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
Dowlatshahi D; Hakim A; Fang J; Sharma M;
Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
[TBL] [Abstract][Full Text] [Related]
39. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
40. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre.
Tveiten A; Mygland A; Ljøstad U; Thomassen L
Emerg Med J; 2009 May; 26(5):324-6. PubMed ID: 19386862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
